Teva
Highly Engaged Employees
Manufacturing · Israel · 10K+ Employees
View Company Info for Free
Overview
Headquarters
124 Dvora Hanevi'a St, Tel Aviv, Tel Avi...Phone Number
+972 39148213Website
www.tevapharm.comRevenue
$17.3 BillionStock Symbol
TEVAIndustry
About Teva
Teva Org Chart
Is Teva your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Teva launches new products
Earning: See what the market has to say on Teva recently announced quarterly report
Funding: Get notified immidiatlly once Teva has new funding data
Check if Teva has recently received funding, and reach out quickly before it becomes old news!
Teva, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Teva
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Teva is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Teva had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Teva as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Teva is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Teva is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Teva.
Teva financials insights
Gather financial insights about Teva, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Multiple Rounds
$11.3B
Multiple Rounds
$7.6B
Debt
$2.4B
Debt
$33.8B
Multiple Rounds
$28.1B
Corporate Investment
$358M
Debt
$4.5B
Debt
$2.3B
Private Equity
$400M
Teva Tech Stack
A closer look at the technologies used by Teva
Most Recent Scoops
Teva News & Media
Teva Announces Launch of Offering of Senior Notes
TEL AVIV, Israel, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today its intention to issue senior notes through its special purpose finance subsidiaries. Teva Pharmaceutical Finance Netherlands II B.V. (“Teva Finance II”) intends to offer EUR-denominated Senior Notes (the “Euro Notes”) and Teva Pharmaceutical Finance Netherlands III B.V. (“Teva Finance III”) and Teva Pharmaceutical Finance Netherlands IV B.V. (“Teva Finance IV”S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial DisciplineTeva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study Transcript
Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study September 2, 2026...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Teva
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is... Read More
